![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](gg2051contents.gif)
Acta Cryst. (2008). E64, m167 [ doi:10.1107/S1600536807065774 ]
Abstract: The title compound, (C11H14N4O4)[SbCl4]·H2O, comprises a protonated doxofyllinium cation [7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-2,6-dioxo-3,7-dihydro-1H-purin-9-ium], an [SbCl4]- anion and a water molecule linked by N-H
O and O-H
Cl hydrogen bonds: the [SbCl4]- anions form centrosymmetric dimers via weak Sb
Cl interactions [Sb
Cl = 3.1159 (9) Å]. The geometrical arrangement in the crystal structure is characterized by slipped
-
stacking of the parallel purine ring systems, with an interplanar separation of 3.32 Å.
Online 12 December 2007
Copyright © International Union of Crystallography
IUCr Webmaster